Chemistry:Actoxumab

From HandWiki
Short description: Chemical compound
Actoxumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetClostridium difficile toxin A
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6476H10000N1740O2010S45
Molar mass145836.11 g·mol−1

Actoxumab is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infection.[1]

This drug, along with bezlotoxumab, was developed through Phase II efficacy trials by a partnership between Medarex Inc and MassBiologics of the University of Massachusetts Medical School.[2] The project was then licensed to Merck & Co., Inc. for further development and commercialization.[3]

A study compared it with bezlotoxumab (that targets CD toxin-B) and found Actoxumab less effective.[4]

References